TY - STD TI - NICE. Chronic obstructive pulmonary disease in over 16s: diagnosis and management | https://www.nice.org.uk/guidance/cg101. Accessed 4 Apr 2019. UR - https://www.nice.org.uk/guidance/cg101 ID - ref1 ER - TY - STD TI - GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2018. [Cited 2019 April 4]. Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. UR - https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf ID - ref2 ER - TY - STD TI - NICE. Chronic obstructive pulmonary disease in over 16s: diagnosis and management 2018. [Cited 2019 April 4]. Available from: https://www.nice.org.uk/guidance/ng115. UR - https://www.nice.org.uk/guidance/ng115 ID - ref3 ER - TY - STD TI - GOLD. Global Initiative for Chronic Obstructive Lung Disease 2019. [Cited 2019 April 4]. Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed 4 Apr 2019. UR - https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf ID - ref4 ER - TY - JOUR AU - Fletcher, C. AU - Peto, R. PY - 1977 DA - 1977// TI - The natural history of chronic airflow obstruction JO - Br Med J VL - 1 UR - https://doi.org/10.1136/bmj.1.6077.1645 DO - 10.1136/bmj.1.6077.1645 ID - Fletcher1977 ER - TY - JOUR AU - Vestbo, J. AU - Anderson, J. A. AU - Brook, R. D. AU - Calverley, P. M. A. AU - Celli, B. R. AU - Crim, C. PY - 2016 DA - 2016// TI - Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(16)30069-1 DO - 10.1016/S0140-6736(16)30069-1 ID - Vestbo2016 ER - TY - JOUR AU - Sutherland, E. R. AU - Allmers, H. AU - Ayas, N. T. AU - Venn, A. J. AU - Martin, R. J. PY - 2003 DA - 2003// TI - Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a metaanalysis JO - Thorax. VL - 58 UR - https://doi.org/10.1136/thorax.58.11.937 DO - 10.1136/thorax.58.11.937 ID - Sutherland2003 ER - TY - JOUR AU - Lapperre, T. S. AU - Snoeck-Stroband, J. B. AU - Gosman, M. M. E. AU - Jansen, D. F. AU - Schadewljk, A. AU - Thladens, H. A. PY - 2009 DA - 2009// TI - Effect of fluticasone with and without Salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease JO - Ann Intern Med VL - 151 UR - https://doi.org/10.7326/0003-4819-151-8-200910200-00004 DO - 10.7326/0003-4819-151-8-200910200-00004 ID - Lapperre2009 ER - TY - STD TI - Calverley PM, Anderson JA, Brook RD, Crim C, Gallot N, Kilbride S, et al. Fluticasone furoate, vilanterol and lung function decline in patients with moderate COPD and heightened cardiovascular risk. Am J Respir Crit Care Med. 2017;197(1):47-55. ID - ref9 ER - TY - JOUR AU - Vestbo, J. AU - Edwards, L. D. AU - Scanlon, P. D. AU - Yates, J. C. AU - Agusti, A. AU - Bakke, P. PY - 2011 DA - 2011// TI - Changes in forced expiratory volume in 1 second over time in COPD JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1105482 DO - 10.1056/NEJMoa1105482 ID - Vestbo2011 ER - TY - JOUR AU - Tashkin, D. P. PY - 2013 DA - 2013// TI - Variations in FEV (1) decline over time in chronic obstructive pulmonary disease and its implications JO - Curr Opin Pulm Med VL - 19 UR - https://doi.org/10.1097/MCP.0b013e32835d8ea4 DO - 10.1097/MCP.0b013e32835d8ea4 ID - Tashkin2013 ER - TY - JOUR AU - Woodcock, A. s. h. l. e. y. AU - Boucot, I. s. a. b. e. l. l. e. AU - Leather, D. a. v. i. d. A. AU - Crawford, J. o. d. i. e. AU - Collier, S. u. s. a. n. AU - Bakerly, N. a. w. a. r. D. i. a. r. AU - Hilton, E. m. m. a. AU - Vestbo, J. ø. r. g. e. n. PY - 2018 DA - 2018// TI - Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability JO - European Respiratory Journal VL - 51 UR - https://doi.org/10.1183/13993003.01531-2017 DO - 10.1183/13993003.01531-2017 ID - Woodcock2018 ER - TY - JOUR AU - Rodrigo, G. J. AU - Price, D. AU - Anzueto, A. AU - Singh, D. AU - Altman, P. AU - Bader, G. PY - 2017 DA - 2017// TI - LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis JO - Int J Chron Obstruct Pulmon Dis VL - 12 UR - https://doi.org/10.2147/COPD.S130482 DO - 10.2147/COPD.S130482 ID - Rodrigo2017 ER - TY - JOUR AU - Rogliani, P. AU - Calzetta, L. AU - Braido, F. AU - Cazzola, M. AU - Clini, E. AU - Pelaia, G. PY - 2018 DA - 2018// TI - LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review JO - Int J Chron Obstruct Pulmon Dis. VL - 13 UR - https://doi.org/10.2147/COPD.S170606 DO - 10.2147/COPD.S170606 ID - Rogliani2018 ER - TY - JOUR AU - Miravitlles, M. AU - Urrutia, G. AU - Mathioudakis, A. G. AU - Ancochea, J. PY - 2017 DA - 2017// TI - Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis JO - Respir Res VL - 18 UR - https://doi.org/10.1186/s12931-017-0683-x DO - 10.1186/s12931-017-0683-x ID - Miravitlles2017 ER - TY - JOUR AU - Horita, N. AU - Miyazawa, N. AU - Tomaru, K. AU - Inoue, M. AU - Kaneko, T. PY - 2015 DA - 2015// TI - Long-acting muscarinic antagonist+long-acting beta agonist versus long-acting beta agonist+inhaled corticosteroid for COPD: A systematic review and meta-analysis JO - Respirology (Carlton, Vic) VL - 20 UR - https://doi.org/10.1111/resp.12603 DO - 10.1111/resp.12603 ID - Horita2015 ER - TY - JOUR AU - Rodrigo, G. J. AU - Castro-Rodriguez, J. A. AU - Plaza, V. PY - 2009 DA - 2009// TI - Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review JO - Chest. VL - 136 UR - https://doi.org/10.1378/chest.09-0821 DO - 10.1378/chest.09-0821 ID - Rodrigo2009 ER - TY - JOUR AU - Grunsven, P. M. AU - Schayck, C. P. AU - Derenna, J. P. AU - Kerstjens, H. A. M. AU - Renkema, T. E. J. AU - Postma, D. S. PY - 1999 DA - 1999// TI - Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis JO - Thorax VL - 54 UR - https://doi.org/10.1136/thx.54.1.7 DO - 10.1136/thx.54.1.7 ID - Grunsven1999 ER - TY - JOUR AU - Higgins, J. P. AU - Altman, D. G. AU - Gotzsche, P. C. AU - Juni, P. AU - Moher, D. AU - Oxman, A. D. PY - 2011 DA - 2011// TI - The Cochrane Collaboration's tool for assessing risk of bias in randomised trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5928 DO - 10.1136/bmj.d5928 ID - Higgins2011 ER - TY - BOOK AU - Altman, D. G. PY - 1991 DA - 1991// TI - Practical statistics for medical research PB - Chapman and Hall CY - London ID - Altman1991 ER - TY - JOUR AU - Auffarth, B. AU - Postma, D. S. AU - Monchy, J. G. R. AU - Mark, T. W. AU - Boorsma, M. AU - Koeter, G. H. PY - 1991 DA - 1991// TI - Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease JO - Thorax VL - 46 UR - https://doi.org/10.1136/thx.46.5.372 DO - 10.1136/thx.46.5.372 ID - Auffarth1991 ER - TY - JOUR AU - Cazzola, M. AU - Lorenzo, G. AU - Perna, F. AU - Calderaro, F. AU - Testi, R. AU - Centanni, S. PY - 2000 DA - 2000// TI - Additive effects of salmeterol and fluticasone or theophylline in COPD JO - Chest VL - 118 UR - https://doi.org/10.1378/chest.118.6.1576 DO - 10.1378/chest.118.6.1576 ID - Cazzola2000 ER - TY - JOUR AU - Lee, S. D. AU - Xie, C. M. AU - Yunus, F. AU - Itoh, Y. AU - Ling, X. AU - Yu, W. C. PY - 2016 DA - 2016// TI - Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: a randomized, multicentre study in East Asia JO - Respirology. VL - 21 UR - https://doi.org/10.1111/resp.12646 DO - 10.1111/resp.12646 ID - Lee2016 ER - TY - JOUR AU - Bourbeau, J. AU - Rouleau, M. Y. AU - Boucher, S. PY - 1998 DA - 1998// TI - Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease JO - Thorax VL - 53 UR - https://doi.org/10.1136/thx.53.6.477 DO - 10.1136/thx.53.6.477 ID - Bourbeau1998 ER - TY - JOUR AU - Ohar, J. A. AU - Crater, G. D. AU - Emmett, A. AU - Ferro, T. J. AU - Morris, A. N. AU - Raphiou, I. PY - 2014 DA - 2014// TI - Fluticasone propionate/salmeterol 250/50 mug versus salmeterol 50 mug after chronic obstructive pulmonary disease exacerbation JO - Respir Res VL - 15 UR - https://doi.org/10.1186/s12931-014-0105-2 DO - 10.1186/s12931-014-0105-2 ID - Ohar2014 ER - TY - JOUR AU - Vestbo, J. AU - Pauwels, R. AU - Anderson, J. A. AU - Jones, P. AU - Calverley, P. PY - 2005 DA - 2005// TI - Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease JO - Thorax VL - 60 UR - https://doi.org/10.1136/thx.2004.025411 DO - 10.1136/thx.2004.025411 ID - Vestbo2005 ER - TY - JOUR AU - Vestbo, J. AU - Papi, A. AU - Corradi, M. AU - Blazhko, V. AU - Montagna, I. AU - Francisco, C. PY - 2017 DA - 2017// TI - Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial JO - Lancet (London, England) VL - 389 UR - https://doi.org/10.1016/S0140-6736(17)30188-5 DO - 10.1016/S0140-6736(17)30188-5 ID - Vestbo2017 ER - TY - JOUR AU - Wise, R. AU - Connett, J. AU - Weinmann, G. AU - Scanlon, P. AU - Skeans, M. PY - 2000 DA - 2000// TI - Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease JO - N Engl J Med VL - 343 ID - Wise2000 ER - TY - JOUR AU - Weir, D. C. AU - Bale, G. A. AU - Bright, P. AU - Sherwood, B. P. PY - 1999 DA - 1999// TI - A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease JO - Clin Exp Allergy VL - 29 UR - https://doi.org/10.1046/j.1365-2222.1999.00021.x DO - 10.1046/j.1365-2222.1999.00021.x ID - Weir1999 ER - TY - JOUR AU - Renkema, T. E. J. AU - Schouten, J. P. AU - Koeter, G. H. AU - Postma, D. S. PY - 1996 DA - 1996// TI - Effects of long-term treatment with corticosteroids in COPD JO - Chest. VL - 109 UR - https://doi.org/10.1378/chest.109.5.1156 DO - 10.1378/chest.109.5.1156 ID - Renkema1996 ER - TY - JOUR AU - Burge, P. S. AU - Calverley, P. M. A. AU - Jones, P. W. AU - Spencer, S. AU - Anderson, J. A. AU - Maslen, T. K. PY - 2000 DA - 2000// TI - Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial JO - Br Med J VL - 320 UR - https://doi.org/10.1136/bmj.320.7245.1297 DO - 10.1136/bmj.320.7245.1297 ID - Burge2000 ER - TY - JOUR AU - Calverley, P. M. A. AU - Spencer, S. AU - Willits, L. AU - Burge, P. S. AU - Jones, P. W. PY - 2003 DA - 2003// TI - Withdrawal from treatment as an outcome in the ISOLDE study of COPD JO - Chest VL - 124 UR - https://doi.org/10.1378/chest.124.4.1350 DO - 10.1378/chest.124.4.1350 ID - Calverley2003 ER - TY - JOUR AU - Pauwels, R. A. AU - Lofdahl, C. G. AU - Laitinen, L. A. AU - Schouten, J. P. AU - Postma, D. S. AU - Pride, N. B. PY - 1999 DA - 1999// TI - Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society study on chronic obstructive pulmonary disease JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199906243402503 DO - 10.1056/NEJM199906243402503 ID - Pauwels1999 ER - TY - JOUR AU - Vestbo, J. AU - Sorensen, T. AU - Lange, P. AU - Brix, A. AU - Tone, P. AU - Viskum, K. PY - 1999 DA - 1999// TI - Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial JO - Lancet. VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)10019-3 DO - 10.1016/S0140-6736(98)10019-3 ID - Vestbo1999 ER - TY - JOUR AU - Calverley, P. M. A. AU - Anderson, J. A. AU - Brook, R. D. AU - Crim, C. AU - Gallot, N. AU - Kilbride, S. PY - 2018 DA - 2018// TI - Fluticasone furoate, vilanterol, and lung function decline in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk JO - Am J Respir Crit Care Med VL - 197 UR - https://doi.org/10.1164/rccm.201610-2086OC DO - 10.1164/rccm.201610-2086OC ID - Calverley2018 ER - TY - JOUR AU - Shaker, S. B. AU - Dirksen, A. AU - Ulrik, C. S. AU - Hestad, M. AU - Stavngaard, T. AU - Laursen, L. C. PY - 2009 DA - 2009// TI - The effect of inhaled corticosteroids on the development of emphysema in smokers assessed by annual computed tomography JO - COPD. VL - 6 UR - https://doi.org/10.1080/15412550902772593 DO - 10.1080/15412550902772593 ID - Shaker2009 ER - TY - JOUR AU - Babu, K. S. AU - Kastelik, J. A. AU - Morjaria, J. B. PY - 2014 DA - 2014// TI - Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective JO - Br J Clin Pharmacol VL - 78 UR - https://doi.org/10.1111/bcp.12334 DO - 10.1111/bcp.12334 ID - Babu2014 ER - TY - JOUR AU - Calverley, P. M. A. AU - Anderson, J. A. AU - Celli, B. AU - Ferguson, G. T. AU - Jenkins, C. AU - Jones, P. W. PY - 2007 DA - 2007// TI - Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa063070 DO - 10.1056/NEJMoa063070 ID - Calverley2007 ER - TY - JOUR AU - Barnes, P. J. AU - Shapiro, S. D. AU - Pauwels, R. A. PY - 2003 DA - 2003// TI - Chronic obstructive pulmonary disease: molecular and cellularmechanisms JO - Eur Respir J VL - 22 UR - https://doi.org/10.1183/09031936.03.00040703 DO - 10.1183/09031936.03.00040703 ID - Barnes2003 ER - TY - JOUR AU - Barnes, P. J. PY - 2008 DA - 2008// TI - Immunology of asthma and chronic obstructive pulmonary disease JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2254 DO - 10.1038/nri2254 ID - Barnes2008 ER - TY - JOUR AU - Usmani, O. S. AU - Ito, K. AU - Maneechotesuwan, K. AU - Ito, M. AU - Johnson, M. AU - Barnes, P. J. PY - 2005 DA - 2005// TI - Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy JO - Am J Respir Crit Care Med VL - 172 UR - https://doi.org/10.1164/rccm.200408-1041OC DO - 10.1164/rccm.200408-1041OC ID - Usmani2005 ER - TY - JOUR AU - Barnes, P. J. PY - 2002 DA - 2002// TI - Scientific rationale for inhaled combination therapy with long-acting β<sub>2</sub>-agonists and corticosteroids JO - Eur Respir J VL - 19 UR - https://doi.org/10.1183/09031936.02.00283202 DO - 10.1183/09031936.02.00283202 ID - Barnes2002 ER - TY - JOUR AU - Tashkin, D. P. AU - Ferguson, G. T. PY - 2013 DA - 2013// TI - Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease JO - Respir Res VL - 14 UR - https://doi.org/10.1186/1465-9921-14-49 DO - 10.1186/1465-9921-14-49 ID - Tashkin2013 ER - TY - JOUR AU - Lal, C. AU - Strange, C. PY - 2017 DA - 2017// TI - A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD JO - Expert Opin Pharmacother VL - 18 UR - https://doi.org/10.1080/14656566.2017.1403583 DO - 10.1080/14656566.2017.1403583 ID - Lal2017 ER - TY - STD TI - Rogliani P, Braido F, Calzetta L, Cazzola M, Clini EM, Pelaia G, et al. Lama/laba fixed combinations for COPD management: A systematic comparative review. American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS. 2018;197(MeetingAbstracts). ID - ref45 ER - TY - JOUR AU - Barnes, N. C. AU - Sharma, R. AU - Lettis, S. AU - Calverley, P. M. PY - 2016 DA - 2016// TI - Blood eosinophils as a marker of response to inhaled corticosteroids in COPD JO - Eur Respir J VL - 47 UR - https://doi.org/10.1183/13993003.01370-2015 DO - 10.1183/13993003.01370-2015 ID - Barnes2016 ER - TY - JOUR AU - Whittaker, H. R. AU - Mullerova, H. AU - Jarvis, D. AU - Barnes, N. C. AU - Jones, P. W. AU - Compton, C. H. PY - 2019 DA - 2019// TI - Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting JO - Int J Chron Obstruct Pulmon Dis VL - 14 UR - https://doi.org/10.2147/COPD.S200919 DO - 10.2147/COPD.S200919 ID - Whittaker2019 ER - TY - STD TI - NICE. Chronic Obstructive Pulmonary Disease: beclometasone, formaterol and glycopyrronium (Trimbow) 2018. [Cited 2019 August 02]. Accessed from: https://www.nice.org.uk/advice/es17/resources/chronic-obstructive-pulmonary-disease-beclometasone-formoterol-and-glycopyrronium-trimbow-pdf-1158120380869. UR - https://www.nice.org.uk/advice/es17/resources/chronic-obstructive-pulmonary-disease-beclometasone-formoterol-and-glycopyrronium-trimbow-pdf-1158120380869 ID - ref48 ER - TY - JOUR AU - Suissa, S. AU - Patenaude, V. AU - Lapi, F. AU - Ernst, P. PY - 2013 DA - 2013// TI - Inhaled corticosteroids in COPD and the risk of serious pneumonia JO - Thorax VL - 68 UR - https://doi.org/10.1136/thoraxjnl-2012-202872 DO - 10.1136/thoraxjnl-2012-202872 ID - Suissa2013 ER - TY - STD TI - Janson C, Johansson G, Stallberg B, Lisspers K, Olsson P, Keininger D, et al. ICS and risk of pneumonia in Swedish COPD patients: The ARCTIC study. Eur Respir J. 2016;48:PA3946. ID - ref50 ER - TY - JOUR AU - Park, H. Y. AU - Man, S. F. AU - Sin, D. D. PY - 2012 DA - 2012// TI - Inhaled corticosteroids for chronic obstructive pulmonary disease JO - BMJ VL - 345 UR - https://doi.org/10.1136/bmj.e6843 DO - 10.1136/bmj.e6843 ID - Park2012 ER - TY - JOUR AU - Gruffydd-Jones, K. AU - Brusselle, G. AU - Jones, R. AU - Miravitlles, M. AU - Baldwin, M. AU - Stewart, R. PY - 2016 DA - 2016// TI - Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational JO - NPJ Prim Care Respir Med VL - 26 UR - https://doi.org/10.1038/npjpcrm.2016.2 DO - 10.1038/npjpcrm.2016.2 ID - Gruffydd-Jones2016 ER - TY - JOUR AU - Jones, P. W. AU - Beeh, K. M. AU - Chapman, K. R. AU - Decramer, M. AU - Mahler, D. A. AU - Wedzicha, J. A. PY - 2014 DA - 2014// TI - Minimal clinically important differences in pharmacological trials JO - Am J Respir Crit Care Med VL - 189 UR - https://doi.org/10.1164/rccm.201310-1863PP DO - 10.1164/rccm.201310-1863PP ID - Jones2014 ER - TY - JOUR AU - Tantucci, C. AU - Modina, D. PY - 2012 DA - 2012// TI - Lung function decline in COPD JO - Int J Chron Obstruct Pulmon Dis VL - 7 UR - https://doi.org/10.2147/COPD.S27480 DO - 10.2147/COPD.S27480 ID - Tantucci2012 ER -